Page 2 - Morphosys News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Morphosys. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Morphosys Today - Breaking & Trending Today
Wells Fargo & Company reaffirmed their overweight rating on shares of MorphoSys (NASDAQ:MOR – Free Report) in a report issued on Monday, Benzinga reports. They currently have a $17.00 price objective on the stock. Several other analysts also recently commented on MOR. Leerink Partnrs restated a market perform rating on shares of MorphoSys in a […] ....
By Adria Calatayud MorphoSys shares jumped after the German biotechnology company agreed to be taken over by Swiss pharmaceutical giant Novartis in an. ....
Reuters first reported on Monday that Switzerland-based Novartis was in advanced talks to acquire MorphoSys, leading to the German biotech firm's shares surging more than 40%. The Swiss group will offer shareholders 68.00 euros per share in cash and take MorphoSys private after the deal, which is contingent on certain conditions, including a minimum acceptance threshold of 65% of MorphoSys' share capital and regulatory clearances, the companies said. ....
Palantir stock surges after the software company posts better-than-expected fourth-quarter revenue growth, while Eli Lilly’s earnings beat estimates. ....